Search Results - "Whayne, Thomas F"

Refine Results
  1. 1

    Clinical Use of Digitalis: A State of the Art Review by Whayne, Thomas F.

    “…The history of digitalis is rich and interesting, with the first use usually attributed to William Withering and his study on the foxglove published in 1785…”
    Get full text
    Journal Article
  2. 2

    Epigenetics in the development, modification, and prevention of cardiovascular disease by Whayne, Thomas F.

    Published in Molecular biology reports (01-04-2015)
    “…Epigenetics has major relevance to all disease processes; cardiovascular (CV) disease and its related conditions are no exception. Epigenetics is defined as…”
    Get full text
    Journal Article
  3. 3

    Non-Traditional Cardiovascular Risk Markers in the Era of Established Major Risk Factors and Multiple Guidelines by Whayne, Thomas F

    Published in Current vascular pharmacology (01-01-2019)
    “…The non-traditional cardiovascular (CV) risk factors that appear to be of most clinical interest include: apolipoprotein A (ApoA), apolipoprotein B (ApoB),…”
    Get more information
    Journal Article
  4. 4

    Thioredoxins in cardiovascular disease by Whayne, Jr, Thomas F, Parinandi, Narasimham, Maulik, Nilanjana

    “…Key thioredoxin (Trx) system components are nicotinamide adenine dinucleotide phosphate (NADPH), Trx reductase (TrxR), and Trx. TrxR catalyzes disulfide…”
    Get more information
    Journal Article
  5. 5

    Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk by Said, Sarmad, Mukherjee, Debabrata, Whayne, Thomas F

    Published in Current vascular pharmacology (01-01-2016)
    “…Cardiovascular (CV) disease is the most common cause of morbidity and mortality worldwide, particularly in the presence of the metabolic syndrome (MetS)…”
    Get more information
    Journal Article
  6. 6

    Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication? by Whayne, Thomas F.

    “…Inflammation as a cardiovascular risk factor has attracted increasing attention . The current standard of care for decreasing the occurrence of cardiovascular…”
    Get full text
    Journal Article
  7. 7

    Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving by Whayne, Thomas F

    Published in Current vascular pharmacology (01-01-2018)
    “…Undersea diving is a sport and commercial industry. Knowledge of potential problems began with Caisson disease or "the bends", first identified with compressed…”
    Get more information
    Journal Article
  8. 8

    Low-Density Lipoprotein Cholesterol (LDL-C): How Low? by Whayne, Thomas F

    Published in Current vascular pharmacology (01-01-2017)
    “…Low-density lipoprotein cholesterol (LDL-C) is a well-established major cardiovascular (CV) risk factor supported by clinical evidence showing decreased…”
    Get more information
    Journal Article
  9. 9

    Unique Coronary Artery Disease Differences in Women as Related to Revascularization by Whayne, Jr, Thomas F, Mukherjee, Debabrata

    Published in Current medicinal chemistry (01-01-2015)
    “…There are significant differences in coronary heart disease (CHD) in women whenever a comparison is made to men and these carry over to revascularization…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Cardiovascular Medicine at High Altitude by Whayne, Thomas F.

    Published in Angiology (01-07-2014)
    “…Altitude physiology began with Paul Bert in 1878. Chronic mountain sickness (CMS) was defined by Carlos Monge in the 1940s in the Peruvian Andes as consisting…”
    Get full text
    Journal Article
  12. 12

    Prevention of Carotid Artery Atherosclerosis: What is the Evidence? by Whayne, Thomas F.

    Published in Angiology (01-09-2017)
    “…Carotid artery atherosclerosis (CAA) represents a significant form of atherosclerosis with stroke as a major consequence. Whether it is a unique form of…”
    Get full text
    Book Review Journal Article
  13. 13

    Genetic Risk, Adherence to a Healthy Lifestyle, and Ischemic Heart Disease by Whayne, Thomas F., Saha, Sibu P.

    Published in Current cardiology reports (01-01-2019)
    “…Purpose of Review The purpose of this review is to investigate and discuss two aspects of coronary artery disease (CAD)—genetic risk and therapeutic lifestyle…”
    Get full text
    Journal Article
  14. 14

    Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes by Whayne, Thomas F, Mukherjee, Debabrata

    Published in Current vascular pharmacology (01-01-2016)
    “…Exercise therapy, especially when supervised on-site in a clinical facility or directed off-site for a home-based program, is an essential component of the…”
    Get more information
    Journal Article
  15. 15

    The Superior Mesenteric Artery: From Syndrome in the Young to Vascular Atherosclerosis in the Old by Beita, Ana Karolina Víquez, Whayne, Thomas F

    “…This review is directed at increasing awareness of two diverse rare upper gastrointestinal problems that occur at opposite ends of the age spectrum and are…”
    Get more information
    Journal Article
  16. 16

    Nutrition and the healthy heart with an exercise boost by Whayne, Jr, Thomas F, Maulik, Nilanjana

    “…In this era of potent medications and major cardiovascular (CV) procedures, the value of nutrition can be forgotten. A healthy diet is essential, regardless of…”
    Get more information
    Journal Article
  17. 17

    Women, the menopause, hormone replacement therapy and coronary heart disease by Whayne, Thomas F, Mukherjee, Debabrata

    Published in Current opinion in cardiology (01-07-2015)
    “…PURPOSE OF REVIEWCardiovascular disease considerations are associated with the menopause. Despite a misconception that women have a minimal risk for coronary…”
    Get full text
    Journal Article
  18. 18

    Carvedilol Versus Metoprolol, But Which Metoprolol? by Whayne, Thomas F., MD, PhD

    “…The major clinical trial of metoprolol, MERIT-HF (Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure), which showed a significantly…”
    Get full text
    Journal Article
  19. 19
  20. 20